Literature DB >> 16039698

Thromboembolic complications in children with cancer.

John T Wiernikowski1, Uma H Athale.   

Abstract

Thrombosis is a significant problem in patients with cancer. The impact of thromboembolism in association with childhood cancer is not clearly defined. Similarly the information of prevention and management of thromboembolic events in children receiving cancer-therapy is limited. This review aims to examine current knowledge regarding the epidemiology, pathophysiology and management of thrombosis in association with cancer in children.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16039698     DOI： 10.1016/j.thromres.2005.06.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


  7 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.

Authors:  Jessica Gartrell; Sue C Kaste; John T Sandlund; Jamie Flerlage; Yinmei Zhou; Cheng Cheng; Jeremie Estepp; Monika L Metzger
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

3.  Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma.

Authors:  Ekrem Unal; Abdullah Yazar; Yavuz Koksal; Umran Caliskan; Yahya Paksoy; Erdal Kalkan
Journal:  Childs Nerv Syst       Date:  2008-05-15       Impact factor: 1.475

4.  THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.

Authors:  Jeanette Greiner; Martin Schrappe; Alexander Claviez; Martin Zimmermann; Charlotte Niemeyer; Reinhard Kolb; Wolfgang Eberl; Frank Berthold; Eva Bergsträsser; Astrid Gnekow; Elisabeth Lassay; Peter Vorwerk; Melchior Lauten; Axel Sauerbrey; Johannes Rischewski; Andreas Beilken; Günter Henze; Wolfgang Korte; Anja Möricke
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

5.  Successful treatment of acute lymphoblastic leukemia in a child with trisomy 21 and complex congenital heart disease with mechanical prosthetic valve.

Authors:  Saima Alvi; Evan Shereck; Manraj K S Heran; George G S Sandor; Shahrad Rod Rassekh
Journal:  Case Rep Pediatr       Date:  2012-10-02

6.  Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?

Authors:  Jacqueline Halton; Kim Nagel; Leonardo R Brandão; Mariana Silva; Paul Gibson; Anthony Chan; Kay Blyth; Kim Hicks; Nagina Parmar; Leslie Paddock; Stephanie Willing; Lehana Thabane; Uma Athale
Journal:  BMC Cancer       Date:  2012-07-26       Impact factor: 4.430

7.  USE OF WARFARIN IN PEDIATRICS: CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS.

Authors:  Bruna Bergmann Santos; Isabela Heineck; Giovanna Webster Negretto
Journal:  Rev Paul Pediatr       Date:  2017-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.